Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Concerning Secukinumab & Psoriasis (Psoriasis vulgaris - Nummular psoriasis - Plaque psoriasis), Secukinumab is approved by both FDA and EMA for moderate to severe Psoriasis (Psoriasis vulgaris - Nummular psoriasis - Plaque psoriasis) in adults and in children from 6 years of age, but there is no specific separate approval for “nummular psoriasis”; it is covered only insofar as it falls under plaque psoriasis (1, 2). By both health authorities the indication was later extended to pediatric patients ≥6 years with moderate to severe plaque ps…